GeneReach Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4171?
Owner TypeNumber of SharesOwnership Percentage
Institutions2,259,9114.9%
General Public43,706,11995.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 5 shareholders own 4.92% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
2.87%
The Vanguard Group, Inc.
1,320,075NT$70.1m0%no data
1.28%
Norges Bank Investment Management
588,657NT$31.3m0%no data
0.64%
Dimensional Fund Advisors LP
295,402NT$15.7m0%no data
0.08%
State Street Global Advisors, Inc.
36,851NT$2.0m0%no data
0.041%
American Century Investment Management Inc
18,926NT$1.0m0%no data